-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on LifeMD, Maintains $10 Price Target

Benzinga·03/10/2026 10:01:53
Listen to the news
BTIG analyst David Larsen reiterates LifeMD (NASDAQ:LFMD) with a Buy and maintains $10 price target.